Faster global financial news!
China's Akeso Says Its Cancer Drug Ivonescimab Outperformed AstraZeneca's Imfinzi in Phase 3 Trial for Biliary Tract Cancer
Chinese biopharmaceutical firm Akeso announced on Wednesday that its immunotherapy drug ivonescimab had outperformed AstraZeneca’s Imfinzi in a head-to-head phase-three trial for biliary tract cancer. Ivonescimab has already been licensed by the US firm Summit Therapeutics in a multibillion-dollar deal.
Source：SCMP商业 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
Previous: Taiwan's Powertech Technology plans to invest US$2.2 billion to build the world's first AI chip panel-level packaging factory, with production expected to begin as early as early 2027, potentially putting it ahead of TSMC.
|
Next: NVIDIA's Q2 Revenue Reaches Record $9.62 Billion, Exceeding Analyst Expectations, Asian Stocks Mixed on Thursday
24H Trending
-
1
Japan plans to explore a blockchain-based 24/7 government bond and stock settlement system, aiming to finalize development plans by early 2027.
-
2
Iranian Rial Hits New All-Time Low of 2 Million Per US Dollar, Driving Up Prices for Essentials by Over 70%
-
3
Bybit Lists MSTUUSDT TradFi Perpetual Contract With Up to 25x Leverage
-
4
Bybit launches INFQUSDT TradFi Perpetual Contract, with up to 25x leverage
-
5
AI is becoming a new gateway to retail, with 38% of surveyed European consumers using it for product research, McKinsey 2026 research finds
-
6
Ethereum (ETH) Price Today and USD Trend Analysis
-
7
Trump administration demands Fed Governor Lisa Cook respond by Wednesday to removal case, citing a mortgage document misstatement as cause
-
8
Cryptex Finance (CTX) Trading Platform and Project Analysis
-
9
OKX Exchange Newbie Guide to Buying Crypto: P2P and Express Buy Tutorials
-
10
PINU Coin Analysis: An Overview of Pi INU, Pulse Inu, and Piccolo Inu Projects
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
